PRESS RELEASE published on 02/21/2023 at 14:30, 3 years 7 months ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 3 years 8 months ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
PRESS RELEASE published on 02/08/2023 at 14:30, 3 years 8 months ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 3 years 8 months ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 3 years 8 months ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
PRESS RELEASE published on 01/30/2023 at 14:30, 3 years 8 months ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 3 years 8 months ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 3 years 8 months ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
PRESS RELEASE published on 01/25/2023 at 14:30, 3 years 8 months ago Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
PRESS RELEASE published on 01/23/2023 at 14:30, 3 years 8 months ago Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
Published on 10/14/2026 at 23:55, 2 hours 39 minutes ago First Helium Announces Strategic Shallow Heavy Oil Acquisition
Published on 10/14/2026 at 23:45, 2 hours 49 minutes ago Polaris Renewable Energy Announces Q3 2026 Investor Call Details
Published on 10/14/2026 at 23:00, 3 hours 34 minutes ago Core Silver Completes Private Placement of $1.287M
Published on 10/14/2026 at 23:00, 3 hours 34 minutes ago ROK Resources Announces Return of Capital and Expanded 2026 Drilling Program
Published on 10/15/2026 at 01:05, 1 hour 29 minutes ago Opella: New study demonstrates successful cough treatment extends beyond symptom relief
Published on 10/14/2026 at 19:32, 7 hours 2 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2026: Earnings below prior year – net sales up – forecast confirmed
Published on 10/14/2026 at 19:05, 7 hours 29 minutes ago Bulgin Introduces 6000 Series Hybrid Buccaneer Connectors for Power and Signal Connectivity
Published on 10/14/2026 at 19:00, 7 hours 34 minutes ago Informations relatives à l’augmentation de capital
Published on 10/14/2026 at 18:00, 8 hours 34 minutes ago CIS : Chiffre d’affaires du 3ème trimestre 2026 supérieur aux attentes : accélération de la croissance et visibilité renforcée.
Published on 10/14/2026 at 18:00, 8 hours 34 minutes ago CIS : Q3 2026 revenue higher than expected: accelerated growth and increased visibility.
Published on 10/14/2026 at 17:40, 8 hours 54 minutes ago Mersen obtient la certification internationale Living Wage pour son engagement en faveur du bien-être de ses collaborateurs
Published on 10/14/2026 at 17:40, 8 hours 54 minutes ago Mersen’s commitment to employee well-being earns it international Living Wage certification
